In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction

Robert E. Marx

doi:10.1016/B978-0-12-410396-2.00031-1

In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction

Robert E. Marx

Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

Original language	English (US)
Title of host publication	Translational Regenerative Medicine
Publisher	Elsevier Inc.
Pages	437-447
Number of pages	11
ISBN (Electronic)	9780124104570
ISBN (Print)	9780124103962
DOIs	https://doi.org/10.1016/B978-0-12-410396-2.00031-1
State	Published - Jan 1 2015

Keywords

Bone marrow aspirate concentrates
In-situ tissue engineering
Multipotent stem cells
Recombinant human bone morphogenetic protien-2

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/B978-0-12-410396-2.00031-1

Fingerprint Dive into the research topics of 'In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction'. Together they form a unique fingerprint.

Cite this

@inbook{1fc2727900cd4844aa8d2b998e700544,

title = "In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction",

abstract = "Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.",

keywords = "Bone marrow aspirate concentrates, In-situ tissue engineering, Multipotent stem cells, Recombinant human bone morphogenetic protien-2",

author = "Marx, {Robert E.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-410396-2.00031-1",

language = "English (US)",

isbn = "9780124103962",

pages = "437--447",

booktitle = "Translational Regenerative Medicine",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - In situ Tissue Engineering Bone Regeneration in Jaw Reconstruction

AU - Marx, Robert E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

AB - Completing the tissue engineering triangle of cells, signal, and matrix by using bone marrow aspirate concentrates, recombinant human bone morphogenetic protein-2/acellular collagen sponge, and crushed cancellous mineralized allogeneic bone predictably regenerates large volumes of histologically and functionally useful bone in jaw reconstruction. This composite graft is used directly in the patient's recipient site and is known in situ tissue engineering.

KW - Bone marrow aspirate concentrates

KW - In-situ tissue engineering

KW - Multipotent stem cells

KW - Recombinant human bone morphogenetic protien-2

UR - http://www.scopus.com/inward/record.url?scp=84942803266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942803266&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-410396-2.00031-1

DO - 10.1016/B978-0-12-410396-2.00031-1

M3 - Chapter

AN - SCOPUS:84942803266

SN - 9780124103962

SP - 437

EP - 447

BT - Translational Regenerative Medicine

PB - Elsevier Inc.

ER -